A hub for developing innovative biopharma technologies in Chicago
Official title: A Chicago Biomedical Consortium Hub of Innovative Technologies for Entrepreneurship and Science (CBC - HITES)
Funded at Northwestern University at Chicago · NIH-10932934 · Data updated 2026-11-12
This study is all about helping researchers in Chicago turn their medical ideas into real treatments for patients, so you could see new therapies and diagnostic tools that improve your health in the future.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | September 25, 2023 |
| Project end | August 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $999,855 |
| NIH project number | 5U01GM152522-02 |
| Project ID | NIH-10932934 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include patients with conditions that could be treated by novel biopharmaceutical therapies.
✕Less likely to help
Patients with conditions that are not addressed by biopharmaceutical innovations may not receive any benefit from this research.
What this research studies
This research initiative aims to enhance the biopharmaceutical landscape in Chicago by fostering entrepreneurship and innovation among academic researchers. It focuses on bridging the gap between university-based biomedical projects and the necessary funding and expertise to bring these ideas to clinical application. By creating a multi-campus service center, the project will support researchers in developing new therapies, including small molecules, biologics, and advanced diagnostic tools. Patients may benefit from the resulting advancements in treatment options that emerge from this collaborative effort.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective biopharmaceutical treatments for various conditions.
How similar studies have gone: Other research initiatives focused on fostering biopharma entrepreneurship have shown promise in enhancing innovation and treatment development, indicating a potential for success in this approach.
Where this research is happening
-
Northwestern University at Chicago
Chicago, United States Active
Researchers
- Principal investigator: Nadig, Satish N — Northwestern University at Chicago
- Study coordinator: Nadig, Satish N
Related research
Other NIH-funded projects on the same topics.
-
High-intensity exercise as a treatment for Parkinson's disease
This study is looking at whether doing high-intensity endurance exercise can help people who have just been diagnosed with Parkinson's disease feel better and slow down their symptoms, especially since current medications don't always do the trick.
-
Software to quickly assess organ dose after radionuclide exposure
This study is creating a helpful software tool that quickly calculates how much radiation your organs absorb after you've taken certain radioactive substances, so you can get better care and treatment based on your individual needs.
-
Investigating innovative approaches to improve health outcomes.
This study is looking for better ways to improve your care and treatment, so you can get more personalized options that work best for you.
-
Investigating innovative approaches to improve health outcomes.
This study is looking for new ways to improve care and treatment for patients, and if you join, you might help test some exciting new methods that could lead to better health for everyone.
-
Investigating innovative approaches to improve health outcomes.
This study is looking for ways to improve care and treatment for patients like you, by trying out new methods that could help manage your health better.
-
Investigating core biological processes
This study is all about exploring important biological processes that affect our health, and it invites patients to help discover new ways to improve care for everyone.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.